GB202011131D0 - Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain - Google Patents

Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain

Info

Publication number
GB202011131D0
GB202011131D0 GBGB2011131.6A GB202011131A GB202011131D0 GB 202011131 D0 GB202011131 D0 GB 202011131D0 GB 202011131 A GB202011131 A GB 202011131A GB 202011131 D0 GB202011131 D0 GB 202011131D0
Authority
GB
United Kingdom
Prior art keywords
cannabidiol
brain
treatment
structural abnormalities
seizures associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2011131.6A
Other versions
GB2597288A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GW Research Ltd
Original Assignee
GW Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GW Research Ltd filed Critical GW Research Ltd
Priority to GB2011131.6A priority Critical patent/GB2597288A/en
Publication of GB202011131D0 publication Critical patent/GB202011131D0/en
Priority to PCT/EP2021/069860 priority patent/WO2022017931A1/en
Publication of GB2597288A publication Critical patent/GB2597288A/en
Pending legal-status Critical Current

Links

GB2011131.6A 2020-07-20 2020-07-20 Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain Pending GB2597288A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB2011131.6A GB2597288A (en) 2020-07-20 2020-07-20 Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
PCT/EP2021/069860 WO2022017931A1 (en) 2020-07-20 2021-07-15 Use of cannabidiol in the treatment of seizures associated with ohtahara syndrome or ohtahara syndrome secondary to aimp1 mutation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2011131.6A GB2597288A (en) 2020-07-20 2020-07-20 Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain

Publications (2)

Publication Number Publication Date
GB202011131D0 true GB202011131D0 (en) 2020-09-02
GB2597288A GB2597288A (en) 2022-01-26

Family

ID=72339069

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2011131.6A Pending GB2597288A (en) 2020-07-20 2020-07-20 Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain

Country Status (2)

Country Link
GB (1) GB2597288A (en)
WO (1) WO2022017931A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2530001B (en) * 2014-06-17 2019-01-16 Gw Pharma Ltd Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
GB2539472A (en) * 2015-06-17 2016-12-21 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy

Also Published As

Publication number Publication date
GB2597288A (en) 2022-01-26
WO2022017931A1 (en) 2022-01-27

Similar Documents

Publication Publication Date Title
GB202011161D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011175D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202110388D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202011130D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202011119D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202011137D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202011131D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202011146D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202011120D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202011155D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202011141D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202011152D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202011143D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abbormalities of the brain
GB202011125D0 (en) Use of cannabidiol in the treatment of seizures associated wiht rare epilepsy syndromes related to structural abnormalities of the brain
GB202011123D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury
GB202011140D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury
GB202011150D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury
GB202011159D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011170D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011134D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011153D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011156D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011158D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011127D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011160D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities